INSP

NELSON MARILYN C

Known title: DirectorCIK: 0001199894

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Barclays Starts Coverage of Inspire Medical with Underweight. Barclays has begun coverage of Inspire Medical Systems and assigned an Underweight rating. The firm set a price target of $65 for the stock. This rating follows the recent analyst activity on the company. The stock is currently near its long‑term support level.

this person other insiders at INSP

Transaction History

INSP▲ Buy$283K
INSP▲ Buy$25K
INSP▲ Buy$52K
INSP▲ Buy$263K
INSP▲ Buy$32K
INSP▲ Buy$2K
INSP▲ Buy$4K
INSP▲ Buy$3K
INSP▲ Buy$4K
INSP▲ Buy$25K
INSP▲ Buy$905
INSP▲ Buy$975
INSP▲ Buy$21K
INSP▲ Buy$2K
INSP▲ Buy$2K
INSP▲ Buy$2K
INSP▲ Buy$2K
INSP▲ Buy$2K
INSP▲ Buy$2K
INSP▲ Buy$2K
INSP▲ Buy$21K
INSP▲ Buy$0
INSP▲ Buy$21K
INSP▲ Buy$21K
INSP▼ Sell$488K
INSP▼ Sell$301K
INSP▼ Sell$3.7M
INSP▼ Sell$412K
INSP▼ Sell$1.3M
INSP▲ Buy$22K
INSP▲ Buy$23K
INSP▲ Buy$23K
INSP▼ Sell$1.3M
INSP▼ Sell$1.4M
INSP▼ Sell$1.3M
INSP▼ Sell$1.3M
INSP▼ Sell$25K
INSP▼ Sell$581K
INSP▼ Sell$645K
INSP▲ Buy$23K
INSP▼ Sell$5.4M
INSP▲ Buy$23K

We use analytics to understand how market-wall is used. No personal data is sold.